Ipatasertib
Quiénes somos
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
Un ensayo de ipatasertib en combinación con atezolizumab
Estudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
